EPISODE · Apr 13, 2023 · 17 MIN
Is This the Breakthrough Moment for Genetic Medicine?
Genetic medicine is poised to unlock more value for patients and investors due to disruptive technologies like mRNA, siRNA and gene editing. With an estimated 27 genetic medicines already approved, RBC’s biotechnology analyst Luca Issi explains how these technologies could be used next, and why companies able to combine the right choice of intervention with strong execution may stand to benefit most.
Embed this episode
NOW PLAYING
Is This the Breakthrough Moment for Genetic Medicine?
0:00
17:25
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Pathfinders in Biopharma?
This episode is 17 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on April 13, 2023.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!